Shipp et al also reported that PKC-β protein expression was positively associated with transcript abundance and closely associated with clinical outcome in a pilot series of DLBCL patients (n = 21; P = 0.03). The gene discussed is PRKCB; the disease is diffuse large B-cell lymphoma.